PRRT Neuroendocrine Tumor Response monitored using Circulating Transcript Analysis: The NETest

PURPOSE: Peptide receptor radionuclide therapy (PRRT) is effective for metastatic/inoperable neuroendocrine tumors (NETs). Imaging response assessment is usually efficient subsequent to treatment completion. Blood biomarkers such as PRRT Predictive Quotient (PPQ) and NETest are effective in real-tim...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur J Nucl Med Mol Imaging
Huvudupphovsmän: Bodei, Lisa, Kidd, Mark S., Singh, Aviral, van der Zwan, Wouter A., Severi, Stefano, Drozdov, Ignat A., Malczewska, Anna, Baum, Richard P., Kwekkeboom, Dik J, Paganelli, Giovanni, Krenning, Eric P., Modlin, Irvin M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515632/
https://ncbi.nlm.nih.gov/pubmed/31838581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-019-04601-3
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk